GERMANTOWN, MD AND HOUSTON, TX / ACCESS Newswire / December 9, 2025 / uBriGene Biosciences, a global CDMO specializing in ...

RNA-based medicines are transforming the way we treat disease—offering targeted, precision therapies for conditions ranging ...

Researchers may have found a way to create synthetic RNA that is more “pure” and cost-effective than previous approaches, expanding opportunities for medicine and therapeutics. According to research ...

A collaborative study by scientists at the University of California, Riverside, and University of Southern California reports ...

Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...

When a gene is expressed, its DNA sequence is transcribed into a molecule known as RNA. Then the cell processes and edits ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

RNA is a central biological macromolecule, now widely harnessed in medicine and nanotechnology. Like proteins, RNA function often depends on its precise three-dimensional structure. A recent study ...

A Northwestern Medicine study published in the Journal of Clinical Investigation has uncovered a connection between a ...

Researchers have used cryo-EM and computational tools to visualize ribozyme assembly, shedding light on life's most versatile ...